Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
8 pending office actions • 7 clients • 8 examiners • 8 art units • 0 of 8 (0%) have an AI response strategy ready
KORUS Patent, LLC handles Biotechnology & Pharmaceuticals and has 864 career applications. Its current docket contains 8 pending office actions, showing ongoing prosecution within an established application record.
The resolved allowance rate is 78.77%, and the average is 2.09 office actions per allowance. The profile therefore reflects an allowance outcome that can be reviewed together with a relatively limited number of examination exchanges associated with allowed matters.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (25%) |
| §112 only | 2 (25%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 3 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SEGED, NEBYATE SAMUEL | 1 | 28.6% | +51.3% |
| MOSS, NATALIE M | 1 | 30.7% | +17.2% |
| KIM, ERIN ASA | 1 | 69.0% | +34.3% |
| TEJANI, ANKIT D | 1 | 81.0% | +16.3% |
| CHAVCHAVADZE, COLLEEN MARGARET | 1 | 57.4% | +40.2% |
| TOICH, SARA KATHERINE | 1 | 49.5% | +47.6% |
| EMCH, GREGORY S | 1 | 48.0% | +43.2% |
| DARRIGRAND, EMILY ANN | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18461870 | HEALTH-PROMOTING FUNCTIONAL SHOE HAVING FUNCTION OF STIMULATING SOLAR PLEXUS POINT | TOICH, SARA KATHERINE | 22d |
| 18624742 | MEDICAL CUTTING INSTRUMENT INCLUDING BURR GUIDE PROTECTOR | TEJANI, ANKIT D | 26d |
| 18795800 | PLASMA AIR PURIFYING APPARATUS | SEGED, NEBYATE SAMUEL | — |
| 18141239 | IMMUNOGENICITY PREDICTION DEVICE, IMMUNOGENICITY PREDICTION METHOD AND COMPUTER PROGRAM FOR SYNTHETIC LONG PEPTIDE DESIGN | EMCH, GREGORY S | — |
| 17909866 | METHOD AND COMPUTER PROGRAM FOR PREDICTING NEOANTIGEN BY USING PEPTIDE SEQUENCE AND HLA ALLELE SEQUENCE | DARRIGRAND, EMILY ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18461870 | HEALTH-PROMOTING FUNCTIONAL SHOE HAVING FUNCTION OF STIMULATING SOLAR PLEXUS POINT | TOICH, SARA KATHERINE | 22d |
| 18624742 | MEDICAL CUTTING INSTRUMENT INCLUDING BURR GUIDE PROTECTOR | TEJANI, ANKIT D | 26d |
| 18795800 | PLASMA AIR PURIFYING APPARATUS | SEGED, NEBYATE SAMUEL | — |
| 18727799 | COMPOSITION FOR CULTRING NK CELLS, COMPRISING ALLOFERON, AND METHOD FOR CULTURING NK CELLS USING SAME | MOSS, NATALIE M | — |
| 18700353 | BODY-WORN URINAL FOR FEMALE PATIENT | KIM, ERIN ASA | — |
| 18614968 | MULTIPURPOSE SLIDING APPARATUS | CHAVCHAVADZE, COLLEEN MARGARET | — |
| 18141239 | IMMUNOGENICITY PREDICTION DEVICE, IMMUNOGENICITY PREDICTION METHOD AND COMPUTER PROGRAM FOR SYNTHETIC LONG PEPTIDE DESIGN | EMCH, GREGORY S | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Theragen Bio Co., Ltd. | 2 |
| Junsys Co., Ltd. | 1 |
| Nk Medics Inc. | 1 |
| Mediruns Co., Ltd. | 1 |
| TECHCORD CO., LTD. | 1 |
| Hankook Rail System Co., Ltd. | 1 |
| SHOEALLS CO., LTD. | 1 |
| Art Unit | Apps |
|---|---|
| 1758 | 1 |
| 1653 | 1 |
| 3781 | 1 |
| 3796 | 1 |
| 3634 | 1 |
| 3785 | 1 |
| 1678 | 1 |
| 1686 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18795800 | PLASMA AIR PURIFYING APPARATUS | Junsys Co., Ltd. | SEGED, NEBYATE SAMUEL | 1758 | §103§112 | Non-Final OA | — | Pending | Aug 06, 2024 |
| 18727799 | COMPOSITION FOR CULTRING NK CELLS, COMPRISING ALLOFERON, AND METHOD FOR CULTURING NK CELLS USING SAME | Nk Medics Inc. | MOSS, NATALIE M | 1653 | §102§103§112DP | Non-Final OA | — | Pending | Jul 10, 2024 |
| 18700353 | BODY-WORN URINAL FOR FEMALE PATIENT | Mediruns Co., Ltd. | KIM, ERIN ASA | 3781 | §112 | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18624742 | MEDICAL CUTTING INSTRUMENT INCLUDING BURR GUIDE PROTECTOR | Techcord Co., Ltd. | TEJANI, ANKIT D | 3796 | §102§103Other | Non-Final OA | 26d | Pending | Apr 02, 2024 |
| 18614968 | MULTIPURPOSE SLIDING APPARATUS | Hankook Rail System Co., Ltd. | CHAVCHAVADZE, COLLEEN MARGARET | 3634 | §112 | Final Rejection | — | Pending | Mar 25, 2024 |
| 18461870 | HEALTH-PROMOTING FUNCTIONAL SHOE HAVING FUNCTION OF STIMULATING SOLAR PLEXUS POINT | Shoealls Co., Ltd. | TOICH, SARA KATHERINE | 3785 | §103§112 | Final Rejection | 22d | Pending | Sep 06, 2023 |
| 18141239 | IMMUNOGENICITY PREDICTION DEVICE, IMMUNOGENICITY PREDICTION METHOD AND COMPUTER PROGRAM FOR SYNTHETIC LONG PEPTIDE DESIGN | Theragen Bio Co., Ltd. | EMCH, GREGORY S | 1678 | §101§103§112 | Non-Final OA | — | Pending | Apr 28, 2023 |
| 17909866 | METHOD AND COMPUTER PROGRAM FOR PREDICTING NEOANTIGEN BY USING PEPTIDE SEQUENCE AND HLA ALLELE SEQUENCE | Theragen Bio Co., Ltd. | DARRIGRAND, EMILY ANN | 1686 | §101§103§112 | Non-Final OA | — | Pending | Sep 07, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial78.8% of resolved applications prosecuted by Korus Patent, LLC were allowed, across 864 applications in USPTO records.
2.09 office actions per allowed application on average.
8 pending office actions as of October 2026, for 7 clients, before 8 examiners in 8 art units.
